Swiss drugmaker Roche (PINK:RHHBY) said today that it bought diabetes management platform mySugr for an undisclosed price. The 2 companies have worked together since 2014.
mySugr’s digital tech enables users to track things like their blood sugar, diabetes medications and physical activity.
Get the full story at our sister site, Drug Delivery Business News.
The post Roche buys mySugr diabetes app appeared first on MassDevice.